Join
Live feed
·
INSIDERFilingvia Quantisnow
Intra-Cellular Therapies Inc. logo

Chairman and CEO Mates Sharon converted options into 61,278 shares and covered exercise/tax liability with 29,977 shares, increasing direct ownership by 3% to 1,135,235 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ITCI· Intra-Cellular Therapies Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ITCI (Intra-Cellular Therapies Inc.) and more on Quantisnow.